Jérôme Clerc
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 13, 2025
Prolonged Normal Thyroid Function After 131I Radioiodine Therapy Using a Minute LT3 Suppression Test (LT3s-RIT) in Patients with Thyroid Unifocal Autonomy and Baseline Detectable TSH.Jérôme Clerc, Paul Bodin-Cufi, Louise Giraud
|Sep 19, 2023
Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer.David Balakirouchenane, Romain Seban, Lionel Groussin
|Feb 11, 2023
MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data.Louis Schubert, Mohamed Lamine Mariko, Jérôme Clerc
|Feb 16, 2022
Redifferentiating Effect of Larotrectinib in NTRK-Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer.Lionel Groussin, Hélène Theodon, Laura Bessiene
|Aug 27, 2021
New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT.Anne-Ségolène Cottereau, Michel Meignan, Christophe Nioche
|Aug 18, 2021
Letter to the Editor: Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer.Lionel Groussin, Laura Bessiene, Jennifer Arrondeau
Pageof 1
